APO Research
Talk to an analyst

APO RESEARCH · REPORT

Febuxostat

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Febuxostat Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchFebuxostat Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Febuxostat Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Febuxostat Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Febuxostat Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Febuxostat Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Febuxostat market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Febuxostat is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Febuxostat is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Febuxostat is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Febuxostat is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Febuxostat include Takeda Pharmaceuticals, Sun Pharma, Mylan, Hengrui Pharma, Teijin Pharma, Prinston Pharmaceutical, MACLEODS, Lupin Limited and Hikma Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Febuxostat, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Febuxostat, also provides the sales of main regions and countries. Of the upcoming market potential for Febuxostat, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Febuxostat sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Febuxostat market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Febuxostat sales, projected growth trends, production technology, application and end-user industry.

Febuxostat Segment by Company

Takeda Pharmaceuticals

Sun Pharma

Mylan

Hengrui Pharma

Teijin Pharma

Prinston Pharmaceutical

MACLEODS

Lupin Limited

Hikma Pharmaceuticals

Alembic Pharmaceuticals

Febuxostat Segment by Type

80mg

40mg

20mg

120mg

Febuxostat Segment by Application

Acute Gout

Chronic Gout

Febuxostat Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Febuxostat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Febuxostat and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Febuxostat.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Febuxostat in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Febuxostat manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Febuxostat sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Febuxostat Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 80mg Major Manufacturers Table 3. 40mg Major Manufacturers Table 4. 20mg Major Manufacturers Table 5. 120mg Major Manufacturers Table 6. Global Febuxostat Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Acute Gout Major Manufacturers Table 8. Chronic Gout Major Manufacturers Table 9. Febuxostat Industry Trends Table 10. Febuxostat Industry Drivers Table 11. Febuxostat Industry Opportunities and Challenges Table 12. Febuxostat Industry Restraints Table 13. Global Febuxostat Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Febuxostat Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Febuxostat Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Febuxostat Revenue Market Share by Region (2021-2026) Table 17. Global Febuxostat Revenue Market Share by Region (2027-2032) Table 18. Global Febuxostat Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 19. Global Febuxostat Sales by Region (2021-2026) & (k tons) Table 20. Global Febuxostat Sales by Region (2027-2032) & (k tons) Table 21. Global Febuxostat Sales Market Share by Region (2021-2026) Table 22. Global Febuxostat Sales Market Share by Region (2027-2032) Table 23. Global Febuxostat Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Febuxostat Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Febuxostat Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Febuxostat Sales Market Share by Manufacturers (2021-2026) Table 27. Global Febuxostat Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global Febuxostat Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Febuxostat Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Febuxostat Manufacturers, Product Type & Application Table 31. Global Febuxostat Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Febuxostat by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Febuxostat Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Febuxostat Revenue Market Share by Type (2021-2026) Table 38. Global Febuxostat Revenue Market Share by Type (2027-2032) Table 39. Global Febuxostat Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 40. Global Febuxostat Sales by Type (2021-2026) & (k tons) Table 41. Global Febuxostat Sales by Type (2027-2032) & (k tons) Table 42. Global Febuxostat Sales Market Share by Type (2021-2026) Table 43. Global Febuxostat Sales Market Share by Type (2027-2032) Table 44. Global Febuxostat Price by Type (2021-2026) & (US$/ton) Table 45. Global Febuxostat Price by Type (2027-2032) & (US$/ton) Table 46. Global Febuxostat Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Febuxostat Revenue Market Share by Application (2021-2026) Table 50. Global Febuxostat Revenue Market Share by Application (2027-2032) Table 51. Global Febuxostat Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 52. Global Febuxostat Sales by Application (2021-2026) & (k tons) Table 53. Global Febuxostat Sales by Application (2027-2032) & (k tons) Table 54. Global Febuxostat Sales Market Share by Application (2021-2026) Table 55. Global Febuxostat Sales Market Share by Application (2027-2032) Table 56. Global Febuxostat Price by Application (2021-2026) & (US$/ton) Table 57. Global Febuxostat Price by Application (2027-2032) & (US$/ton) Table 58. Takeda Pharmaceuticals Company Information Table 59. Takeda Pharmaceuticals Business Overview Table 60. Takeda Pharmaceuticals Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Takeda Pharmaceuticals Febuxostat Product Portfolio Table 62. Takeda Pharmaceuticals Recent Development Table 63. Sun Pharma Company Information Table 64. Sun Pharma Business Overview Table 65. Sun Pharma Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Sun Pharma Febuxostat Product Portfolio Table 67. Sun Pharma Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Mylan Febuxostat Product Portfolio Table 72. Mylan Recent Development Table 73. Hengrui Pharma Company Information Table 74. Hengrui Pharma Business Overview Table 75. Hengrui Pharma Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Hengrui Pharma Febuxostat Product Portfolio Table 77. Hengrui Pharma Recent Development Table 78. Teijin Pharma Company Information Table 79. Teijin Pharma Business Overview Table 80. Teijin Pharma Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Teijin Pharma Febuxostat Product Portfolio Table 82. Teijin Pharma Recent Development Table 83. Prinston Pharmaceutical Company Information Table 84. Prinston Pharmaceutical Business Overview Table 85. Prinston Pharmaceutical Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Prinston Pharmaceutical Febuxostat Product Portfolio Table 87. Prinston Pharmaceutical Recent Development Table 88. MACLEODS Company Information Table 89. MACLEODS Business Overview Table 90. MACLEODS Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. MACLEODS Febuxostat Product Portfolio Table 92. MACLEODS Recent Development Table 93. Lupin Limited Company Information Table 94. Lupin Limited Business Overview Table 95. Lupin Limited Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Lupin Limited Febuxostat Product Portfolio Table 97. Lupin Limited Recent Development Table 98. Hikma Pharmaceuticals Company Information Table 99. Hikma Pharmaceuticals Business Overview Table 100. Hikma Pharmaceuticals Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Hikma Pharmaceuticals Febuxostat Product Portfolio Table 102. Hikma Pharmaceuticals Recent Development Table 103. Alembic Pharmaceuticals Company Information Table 104. Alembic Pharmaceuticals Business Overview Table 105. Alembic Pharmaceuticals Febuxostat Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Alembic Pharmaceuticals Febuxostat Product Portfolio Table 107. Alembic Pharmaceuticals Recent Development Table 108. North America Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Febuxostat Sales by Type (2021-2026) & (k tons) Table 111. North America Febuxostat Sales by Type (2027-2032) & (k tons) Table 112. North America Febuxostat Sales Price by Type (2021-2026) & (US$/ton) Table 113. North America Febuxostat Sales Price by Type (2027-2032) & (US$/ton) Table 114. North America Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Febuxostat Sales by Application (2021-2026) & (k tons) Table 117. North America Febuxostat Sales by Application (2027-2032) & (k tons) Table 118. North America Febuxostat Sales Price by Application (2021-2026) & (US$/ton) Table 119. North America Febuxostat Sales Price by Application (2027-2032) & (US$/ton) Table 120. North America Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Febuxostat Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Febuxostat Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Febuxostat Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 124. North America Febuxostat Sales by Country (2021-2026) & (k tons) Table 125. North America Febuxostat Sales by Country (2027-2032) & (k tons) Table 126. North America Febuxostat Sales Price by Country (2021-2026) & (US$/ton) Table 127. North America Febuxostat Sales Price by Country (2027-2032) & (US$/ton) Table 128. United States Febuxostat Revenue (2021-2032) & (US$ Million) Table 129. Canada Febuxostat Revenue (2021-2032) & (US$ Million) Table 130. Mexico Febuxostat Revenue (2021-2032) & (US$ Million) Table 131. Europe Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Febuxostat Sales by Type (2021-2026) & (k tons) Table 134. Europe Febuxostat Sales by Type (2027-2032) & (k tons) Table 135. Europe Febuxostat Sales Price by Type (2021-2026) & (US$/ton) Table 136. Europe Febuxostat Sales Price by Type (2027-2032) & (US$/ton) Table 137. Europe Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe Febuxostat Sales by Application (2021-2026) & (k tons) Table 140. Europe Febuxostat Sales by Application (2027-2032) & (k tons) Table 141. Europe Febuxostat Sales Price by Application (2021-2026) & (US$/ton) Table 142. Europe Febuxostat Sales Price by Application (2027-2032) & (US$/ton) Table 143. Europe Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe Febuxostat Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe Febuxostat Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe Febuxostat Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 147. Europe Febuxostat Sales by Country (2021-2026) & (k tons) Table 148. Europe Febuxostat Sales by Country (2027-2032) & (k tons) Table 149. Europe Febuxostat Sales Price by Country (2021-2026) & (US$/ton) Table 150. Europe Febuxostat Sales Price by Country (2027-2032) & (US$/ton) Table 151. Germany Febuxostat Revenue (2021-2032) & (US$ Million) Table 152. France Febuxostat Revenue (2021-2032) & (US$ Million) Table 153. U.K. Febuxostat Revenue (2021-2032) & (US$ Million) Table 154. Italy Febuxostat Revenue (2021-2032) & (US$ Million) Table 155. Russia Febuxostat Revenue (2021-2032) & (US$ Million) Table 156. Spain Febuxostat Revenue (2021-2032) & (US$ Million) Table 157. Netherlands Febuxostat Revenue (2021-2032) & (US$ Million) Table 158. Switzerland Febuxostat Revenue (2021-2032) & (US$ Million) Table 159. Sweden Febuxostat Revenue (2021-2032) & (US$ Million) Table 160. Poland Febuxostat Revenue (2021-2032) & (US$ Million) Table 161. China Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 162. China Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 163. China Febuxostat Sales by Type (2021-2026) & (k tons) Table 164. China Febuxostat Sales by Type (2027-2032) & (k tons) Table 165. China Febuxostat Sales Price by Type (2021-2026) & (US$/ton) Table 166. China Febuxostat Sales Price by Type (2027-2032) & (US$/ton) Table 167. China Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 168. China Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 169. China Febuxostat Sales by Application (2021-2026) & (k tons) Table 170. China Febuxostat Sales by Application (2027-2032) & (k tons) Table 171. China Febuxostat Sales Price by Application (2021-2026) & (US$/ton) Table 172. China Febuxostat Sales Price by Application (2027-2032) & (US$/ton) Table 173. Asia Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia Febuxostat Sales by Type (2021-2026) & (k tons) Table 176. Asia Febuxostat Sales by Type (2027-2032) & (k tons) Table 177. Asia Febuxostat Sales Price by Type (2021-2026) & (US$/ton) Table 178. Asia Febuxostat Sales Price by Type (2027-2032) & (US$/ton) Table 179. Asia Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia Febuxostat Sales by Application (2021-2026) & (k tons) Table 182. Asia Febuxostat Sales by Application (2027-2032) & (k tons) Table 183. Asia Febuxostat Sales Price by Application (2021-2026) & (US$/ton) Table 184. Asia Febuxostat Sales Price by Application (2027-2032) & (US$/ton) Table 185. Asia Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia Febuxostat Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia Febuxostat Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia Febuxostat Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 189. Asia Febuxostat Sales by Country (2021-2026) & (k tons) Table 190. Asia Febuxostat Sales by Country (2027-2032) & (k tons) Table 191. Asia Febuxostat Sales Price by Country (2021-2026) & (US$/ton) Table 192. Asia Febuxostat Sales Price by Country (2027-2032) & (US$/ton) Table 193. Japan Febuxostat Revenue (2021-2032) & (US$ Million) Table 194. South Korea Febuxostat Revenue (2021-2032) & (US$ Million) Table 195. India Febuxostat Revenue (2021-2032) & (US$ Million) Table 196. Australia Febuxostat Revenue (2021-2032) & (US$ Million) Table 197. Taiwan Febuxostat Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia Febuxostat Revenue (2021-2032) & (US$ Million) Table 199. SAMEA Febuxostat Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Febuxostat Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Febuxostat Sales by Type (2021-2026) & (k tons) Table 202. SAMEA Febuxostat Sales by Type (2027-2032) & (k tons) Table 203. SAMEA Febuxostat Sales Price by Type (2021-2026) & (US$/ton) Table 204. SAMEA Febuxostat Sales Price by Type (2027-2032) & (US$/ton) Table 205. SAMEA Febuxostat Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA Febuxostat Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA Febuxostat Sales by Application (2021-2026) & (k tons) Table 208. SAMEA Febuxostat Sales by Application (2027-2032) & (k tons) Table 209. SAMEA Febuxostat Sales Price by Application (2021-2026) & (US$/ton) Table 210. SAMEA Febuxostat Sales Price by Application (2027-2032) & (US$/ton) Table 211. SAMEA Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA Febuxostat Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA Febuxostat Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA Febuxostat Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 215. SAMEA Febuxostat Sales by Country (2021-2026) & (k tons) Table 216. SAMEA Febuxostat Sales by Country (2027-2032) & (k tons) Table 217. SAMEA Febuxostat Sales Price by Country (2021-2026) & (US$/ton) Table 218. SAMEA Febuxostat Sales Price by Country (2027-2032) & (US$/ton) Table 219. Brazil Febuxostat Revenue (2021-2032) & (US$ Million) Table 220. Argentina Febuxostat Revenue (2021-2032) & (US$ Million) Table 221. Chile Febuxostat Revenue (2021-2032) & (US$ Million) Table 222. Colombia Febuxostat Revenue (2021-2032) & (US$ Million) Table 223. Peru Febuxostat Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia Febuxostat Revenue (2021-2032) & (US$ Million) Table 225. Israel Febuxostat Revenue (2021-2032) & (US$ Million) Table 226. UAE Febuxostat Revenue (2021-2032) & (US$ Million) Table 227. Turkey Febuxostat Revenue (2021-2032) & (US$ Million) Table 228. Iran Febuxostat Revenue (2021-2032) & (US$ Million) Table 229. Egypt Febuxostat Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. Febuxostat Distributors List Table 233. Febuxostat Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. Febuxostat Image Figure 2. Global Febuxostat Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Febuxostat Market Size Share 2021 VS 2025 VS 2032 Figure 4. 80mg Image Figure 5. 40mg Image Figure 6. 20mg Image Figure 7. 120mg Image Figure 8. Global Febuxostat Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Febuxostat Market Size Share 2021 VS 2025 VS 2032 Figure 10. Acute Gout Image Figure 11. Chronic Gout Image Figure 12. Global Febuxostat Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Febuxostat Revenue (2021-2032) & (US$ Million) Figure 14. Global Febuxostat Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Febuxostat Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Febuxostat Revenue Market Share by Region (2021-2032) Figure 17. Global Febuxostat Sales (2021-2032) & (k tons) Figure 18. Global Febuxostat Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 19. Global Febuxostat Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Febuxostat Sales YoY (2021-2032) & (k tons) Figure 21. Europe Febuxostat Sales YoY (2021-2032) & (k tons) Figure 22. China Febuxostat Sales YoY (2021-2032) & (k tons) Figure 23. Asia (Excluding China) Febuxostat Sales YoY (2021-2032) & (k tons) Figure 24. South America, Middle East and Africa Febuxostat Sales YoY (2021-2032) & (k tons) Figure 25. Global Febuxostat Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Febuxostat Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Febuxostat Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Febuxostat Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Febuxostat Revenue Market Share by Type (2021-2032) Figure 31. Global Febuxostat Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 32. Global Febuxostat Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Febuxostat Sales Market Share by Type (2021-2032) Figure 34. Global Febuxostat Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Febuxostat Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Febuxostat Revenue Market Share by Application (2021-2032) Figure 37. Global Febuxostat Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 38. Global Febuxostat Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Febuxostat Sales Market Share by Application (2021-2032) Figure 40. North America Febuxostat Revenue Share by Type (2021-2032) Figure 41. North America Febuxostat Sales Share by Type (2021-2032) Figure 42. North America Febuxostat Revenue Share by Application (2021-2032) Figure 43. North America Febuxostat Sales Share by Application (2021-2032) Figure 44. North America Febuxostat Revenue Share by Country (2021-2032) Figure 45. North America Febuxostat Sales Share by Country (2021-2032) Figure 46. Europe Febuxostat Revenue Share by Type (2021-2032) Figure 47. Europe Febuxostat Sales Share by Type (2021-2032) Figure 48. Europe Febuxostat Revenue Share by Application (2021-2032) Figure 49. Europe Febuxostat Sales Share by Application (2021-2032) Figure 50. Europe Febuxostat Revenue Share by Country (2021-2032) Figure 51. Europe Febuxostat Sales Share by Country (2021-2032) Figure 52. China Febuxostat Revenue Share by Type (2021-2032) Figure 53. China Febuxostat Sales Share by Type (2021-2032) Figure 54. China Febuxostat Revenue Share by Application (2021-2032) Figure 55. China Febuxostat Sales Share by Application (2021-2032) Figure 56. Asia Febuxostat Revenue Share by Type (2021-2032) Figure 57. Asia Febuxostat Sales Share by Type (2021-2032) Figure 58. Asia Febuxostat Revenue Share by Application (2021-2032) Figure 59. Asia Febuxostat Sales Share by Application (2021-2032) Figure 60. Asia Febuxostat Revenue Share by Country (2021-2032) Figure 61. Asia Febuxostat Sales Share by Country (2021-2032) Figure 62. SAMEA Febuxostat Revenue Share by Type (2021-2032) Figure 63. SAMEA Febuxostat Sales Share by Type (2021-2032) Figure 64. SAMEA Febuxostat Revenue Share by Application (2021-2032) Figure 65. SAMEA Febuxostat Sales Share by Application (2021-2032) Figure 66. SAMEA Febuxostat Revenue Share by Country (2021-2032) Figure 67. SAMEA Febuxostat Sales Share by Country (2021-2032) Figure 68. Febuxostat Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Febuxostat Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 80mg
  • 40mg
  • 20mg
  • 120mg
Applications
  • Acute Gout
  • Chronic Gout
Companies covered
  • Takeda Pharmaceuticals
  • Sun Pharma
  • Mylan
  • Hengrui Pharma
  • Teijin Pharma
  • Prinston Pharmaceutical
  • MACLEODS
  • Lupin Limited
  • Hikma Pharmaceuticals
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Febuxostat Market by Type
  3. 1.2.1 Global Febuxostat Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 80mg
  5. 1.2.3 40mg
  6. 1.2.4 20mg
  7. 1.2.5 120mg
  8. 1.3 Febuxostat Market by Application
  9. 1.3.1 Global Febuxostat Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Acute Gout
  11. 1.3.3 Chronic Gout
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Febuxostat Market Dynamics
  1. 2.1 Febuxostat Industry Trends
  2. 2.2 Febuxostat Industry Drivers
  3. 2.3 Febuxostat Industry Opportunities and Challenges
  4. 2.4 Febuxostat Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Febuxostat Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Febuxostat Revenue by Region
  3. 3.2.1 Global Febuxostat Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Febuxostat Revenue by Region (2021-2026)
  5. 3.2.3 Global Febuxostat Revenue by Region (2027-2032)
  6. 3.2.4 Global Febuxostat Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Febuxostat Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Febuxostat Sales by Region
  9. 3.4.1 Global Febuxostat Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Febuxostat Sales by Region (2021-2026)
  11. 3.4.3 Global Febuxostat Sales by Region (2027-2032)
  12. 3.4.4 Global Febuxostat Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Febuxostat Revenue by Manufacturers
  2. 4.1.1 Global Febuxostat Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Febuxostat Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Febuxostat Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Febuxostat Sales by Manufacturers
  6. 4.2.1 Global Febuxostat Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Febuxostat Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Febuxostat Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Febuxostat Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Febuxostat Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Febuxostat Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Febuxostat Manufacturers, Product Type & Application
  13. 4.7 Global Febuxostat Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Febuxostat Market CR5 and HHI
  16. 4.8.2 2025 Febuxostat Tier 1, Tier 2, and Tier 3
5 Febuxostat Market by Type
  1. 5.1 Global Febuxostat Revenue by Type
  2. 5.1.1 Global Febuxostat Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Febuxostat Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Febuxostat Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Febuxostat Sales by Type
  6. 5.2.1 Global Febuxostat Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Febuxostat Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Febuxostat Sales Market Share by Type (2021-2032)
  9. 5.3 Global Febuxostat Price by Type
6 Febuxostat Market by Application
  1. 6.1 Global Febuxostat Revenue by Application
  2. 6.1.1 Global Febuxostat Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Febuxostat Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Febuxostat Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Febuxostat Sales by Application
  6. 6.2.1 Global Febuxostat Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Febuxostat Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Febuxostat Sales Market Share by Application (2021-2032)
  9. 6.3 Global Febuxostat Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals
  2. 7.1.1 Takeda Pharmaceuticals Company Information
  3. 7.1.2 Takeda Pharmaceuticals Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Febuxostat Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Recent Developments
  7. 7.2 Sun Pharma
  8. 7.2.1 Sun Pharma Company Information
  9. 7.2.2 Sun Pharma Business Overview
  10. 7.2.3 Sun Pharma Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharma Febuxostat Product Portfolio
  12. 7.2.5 Sun Pharma Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Febuxostat Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Hengrui Pharma
  20. 7.4.1 Hengrui Pharma Company Information
  21. 7.4.2 Hengrui Pharma Business Overview
  22. 7.4.3 Hengrui Pharma Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hengrui Pharma Febuxostat Product Portfolio
  24. 7.4.5 Hengrui Pharma Recent Developments
  25. 7.5 Teijin Pharma
  26. 7.5.1 Teijin Pharma Company Information
  27. 7.5.2 Teijin Pharma Business Overview
  28. 7.5.3 Teijin Pharma Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Teijin Pharma Febuxostat Product Portfolio
  30. 7.5.5 Teijin Pharma Recent Developments
  31. 7.6 Prinston Pharmaceutical
  32. 7.6.1 Prinston Pharmaceutical Company Information
  33. 7.6.2 Prinston Pharmaceutical Business Overview
  34. 7.6.3 Prinston Pharmaceutical Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Prinston Pharmaceutical Febuxostat Product Portfolio
  36. 7.6.5 Prinston Pharmaceutical Recent Developments
  37. 7.7 MACLEODS
  38. 7.7.1 MACLEODS Company Information
  39. 7.7.2 MACLEODS Business Overview
  40. 7.7.3 MACLEODS Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MACLEODS Febuxostat Product Portfolio
  42. 7.7.5 MACLEODS Recent Developments
  43. 7.8 Lupin Limited
  44. 7.8.1 Lupin Limited Company Information
  45. 7.8.2 Lupin Limited Business Overview
  46. 7.8.3 Lupin Limited Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lupin Limited Febuxostat Product Portfolio
  48. 7.8.5 Lupin Limited Recent Developments
  49. 7.9 Hikma Pharmaceuticals
  50. 7.9.1 Hikma Pharmaceuticals Company Information
  51. 7.9.2 Hikma Pharmaceuticals Business Overview
  52. 7.9.3 Hikma Pharmaceuticals Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hikma Pharmaceuticals Febuxostat Product Portfolio
  54. 7.9.5 Hikma Pharmaceuticals Recent Developments
  55. 7.10 Alembic Pharmaceuticals
  56. 7.10.1 Alembic Pharmaceuticals Company Information
  57. 7.10.2 Alembic Pharmaceuticals Business Overview
  58. 7.10.3 Alembic Pharmaceuticals Febuxostat Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Alembic Pharmaceuticals Febuxostat Product Portfolio
  60. 7.10.5 Alembic Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Febuxostat Market Size by Type
  2. 8.1.1 North America Febuxostat Revenue by Type (2021-2032)
  3. 8.1.2 North America Febuxostat Sales by Type (2021-2032)
  4. 8.1.3 North America Febuxostat Price by Type (2021-2032)
  5. 8.2 North America Febuxostat Market Size by Application
  6. 8.2.1 North America Febuxostat Revenue by Application (2021-2032)
  7. 8.2.2 North America Febuxostat Sales by Application (2021-2032)
  8. 8.2.3 North America Febuxostat Price by Application (2021-2032)
  9. 8.3 North America Febuxostat Market Size by Country
  10. 8.3.1 North America Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Febuxostat Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Febuxostat Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Febuxostat Market Size by Type
  2. 9.1.1 Europe Febuxostat Revenue by Type (2021-2032)
  3. 9.1.2 Europe Febuxostat Sales by Type (2021-2032)
  4. 9.1.3 Europe Febuxostat Price by Type (2021-2032)
  5. 9.2 Europe Febuxostat Market Size by Application
  6. 9.2.1 Europe Febuxostat Revenue by Application (2021-2032)
  7. 9.2.2 Europe Febuxostat Sales by Application (2021-2032)
  8. 9.2.3 Europe Febuxostat Price by Application (2021-2032)
  9. 9.3 Europe Febuxostat Market Size by Country
  10. 9.3.1 Europe Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Febuxostat Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Febuxostat Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Febuxostat Market Size by Type
  2. 10.1.1 China Febuxostat Revenue by Type (2021-2032)
  3. 10.1.2 China Febuxostat Sales by Type (2021-2032)
  4. 10.1.3 China Febuxostat Price by Type (2021-2032)
  5. 10.2 China Febuxostat Market Size by Application
  6. 10.2.1 China Febuxostat Revenue by Application (2021-2032)
  7. 10.2.2 China Febuxostat Sales by Application (2021-2032)
  8. 10.2.3 China Febuxostat Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Febuxostat Market Size by Type
  2. 11.1.1 Asia Febuxostat Revenue by Type (2021-2032)
  3. 11.1.2 Asia Febuxostat Sales by Type (2021-2032)
  4. 11.1.3 Asia Febuxostat Price by Type (2021-2032)
  5. 11.2 Asia Febuxostat Market Size by Application
  6. 11.2.1 Asia Febuxostat Revenue by Application (2021-2032)
  7. 11.2.2 Asia Febuxostat Sales by Application (2021-2032)
  8. 11.2.3 Asia Febuxostat Price by Application (2021-2032)
  9. 11.3 Asia Febuxostat Market Size by Country
  10. 11.3.1 Asia Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Febuxostat Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Febuxostat Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Febuxostat Market Size by Type
  2. 12.1.1 SAMEA Febuxostat Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Febuxostat Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Febuxostat Price by Type (2021-2032)
  5. 12.2 SAMEA Febuxostat Market Size by Application
  6. 12.2.1 SAMEA Febuxostat Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Febuxostat Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Febuxostat Price by Application (2021-2032)
  9. 12.3 SAMEA Febuxostat Market Size by Country
  10. 12.3.1 SAMEA Febuxostat Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Febuxostat Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Febuxostat Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Febuxostat Value Chain Analysis
  2. 13.1.1 Febuxostat Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Febuxostat Production Mode & Process
  6. 13.2 Febuxostat Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Febuxostat Distributors
  9. 13.2.3 Febuxostat Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst